Neonatal fungemia caused by Hansenula anomala: a case report.
Hansenula anomala, an ascosporogenous yeast of the class Ascomycetes, is a free-living organism isolated from the environment. It is also a part of the normal or transient flora of the human throat and alimentary tract. It has been recognized as an opportunistic pathogen and its infection is very rare. A premature infant, a victim of right femoral osteomyelitis and right hip arthritis caused by oxacillin-resistant Staphylococcus aureus, was found to have developed H. anomala fungemia just before the initiation of the antimicrobial therapy with teicoplanin. Antifungal agents (fluconazole and amphotericin B) were prescribed for 10 days despite the absence of clinical sign of systemic fungal infection. His general condition remained good, with a subsequent sterile blood culture. The patient was discharged after completing 5 weeks of antimicrobial therapy, and he remained well during follow-up at our outpatient clinics. Here, we also review the risk factors, the clinical presentations, and the therapeutic strategies of H. anomala infection in the literature.
Department of Pediatrics, Taichung Veterans General Hospital, Taiwan, ROC.
J S
JS
Ma
P Y
PY
Chen
C H
CH
Chen
C S
CS
Chi
D016469:Fungemia / Q000188:drug therapy / Q000209:etiology*; D006801:Humans; D007231:Infant, Newborn; D008297:Male; D010843:Pichia / Q000187:drug effects / Q000302:isolation & purification*